🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Three hundred women with severe premenstrual syndrome will be divided into ...
Status
Unknown
Location
BeniSuef University hospitals
Start Date
2015-10
Trial ID
NCT02562053
Treatments Being Tested
A combined oral contraceptive (COC) containing 15 mg E4 and 3 mg DRSP admin...
Status
Completed
Location
Dinox BV
Start Date
2017-02-07
Trial ID
NCT03091595
Treatments Being Tested
The objectives of this study were to evaluate the efficacy and safety of dr...
Status
Completed
Location
Multiple Locations
Start Date
2003-01
Trial ID
NCT00656981
Treatments Being Tested
We investigate parameters of hemocoagulation and lipoperoxidation in women ...
Status
Unknown
Location
Tyumen State Medical Academy
Start Date
2013-12
Trial ID
NCT02027337
Treatments Being Tested
The objectives of this study were to evaluate the efficacy and safety of dr...
Status
Completed
Location
Multiple Locations
Start Date
2003-01
Trial ID
NCT00651469
Treatments Being Tested
The purpose of this study is to compare bleeding pattern of contraceptive Y...
Status
Completed
Location
Multiple Locations
Start Date
2004-03
Trial ID
NCT00624130
The purpose of this study is to evaluate the efficacy and safety of YAZ com...
Status
Completed
Location
Multiple Locations
Start Date
2009-01
Trial ID
NCT00824187
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of YAZ (dr...
Status
Completed
Location
Multiple Locations
Start Date
2008-12
Trial ID
NCT00818519
Treatments Being Tested
The purpose of this study is to examine and compare the uptake of levomefol...
Status
Completed
Location
Nuvisan GmbH
Start Date
2006-12
Trial ID
NCT01258660
The purpose of this study is to evaluate the effect of SUZ on the pharmacok...
Status
Completed
Location
Celerion - Tempe
Start Date
2025-02-25
Trial ID
NCT06820307
Treatments Being Tested